quantisnow
FeedTopReportsPricing
⌘K
Live feed
00:15:10·1340d
SECFiling
Turning Point Therapeutics Inc. logo

SEC Form EFFECT filed by Turning Point Therapeutics Inc.

TPTX· Turning Point Therapeutics Inc.
Health Care
Original source

Companies

  • TPTX
    Turning Point Therapeutics Inc.
    Health Care

Recent analyst ratings

  • May 20UpdateBofA Securities$58.00
  • Mar 1UpdateStifel$45.00
  • Feb 10UpdateWells Fargo$85.00
  • Jan 21UpdateOppenheimer$105.00
  • Dec 7UpdateCowen & Co.-
  • Nov 10UpdateOppenheimer$115.00

Related

  • PR540d
    Axonis Therapeutics Announces $115 Million Series A Financing
  • PR630d
    venBio Raises $528 Million Venture Capital Fund Focused on Life Science Companies
  • PR786d
    NorthStar Medical Technologies, LLC Announces Appointment of Barbara Bodem and David Keeling to Board of Managers
  • PR897d
    Global Precision Medicine Market Size Demonstrates Consistent Growth with a CAGR of 11.12%, with North America Taking a Leading Role
  • SEC1333d
    SEC Form 15-12G filed by Turning Point Therapeutics Inc.
  • INSIDER1345d
    SEC Form 4 filed by Nicholson Garry A (tax withholding)
  • INSIDER1345d
    SEC Form 4 filed by Machado Patrick (withholding obligation)
  • INSIDER1345d
    SEC Form 4: George Simeon returned $171,278,160 worth of shares to the company (2,253,660 units at $76.00) to cover taxes
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022